SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 23, 2004
SAFEGUARD SCIENTIFICS, INC.
| PENNSYLVANIA | 1-5620 | 23-1609753 | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||
| 800 The Safeguard Building, 435 Devon Park Drive, Wayne, PA | 19087-1945 | |||
| (Address of principal executive offices) | (Zip Code) | |||
Registrant’s telephone number, including area code: (610) 293-0600
Not applicable
ITEM 5.Other Events
On February 23, 2004, Safeguard Scientifics, Inc. issued a press release announcing that it had closed the private placement of $150 million in aggregate principal amount of its 2.625% convertible senior debentures due 2024 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Safeguard also announced that it completed the repurchase of $42 million of face value of its 5% Convertible Subordinated Notes due June 15, 2006 using a portion of the proceeds from the sale of this offering.
The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
ITEM 7. Financial Statements and Exhibits
| (a) | Financial Statements of Businesses Acquired. | |||
| None. | ||||
| (b) | Pro Forma Financial Information. | |||
| None. | ||||
| (c) | Exhibits | |||
| 99.1 Press Release of Safeguard Scientifics, Inc. dated February 23, 2004. | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Safeguard Scientifics, Inc. | ||||
| Dated: February 23, 2004 | By: | CHRISTOPHER J. DAVIS | ||
| Christopher J. Davis Managing Director and Chief Financial Officer | ||||
Exhibit Index
99.1 Press release dated February 23, 2004 issued by Safeguard Scientifics, Inc.